ALKAMI TECHNOLOGY INC
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
ALKT$14.16-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(11,433) | $(16,963) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization expense | 2,562 | 2,586 |
| Accrued interest on marketable securities, net | (294) | (398) |
| Stock-based compensation expense | 13,552 | 11,440 |
| Amortization of debt issuance costs | 32 | 45 |
| Gain on financial instruments | (112) | (210) |
| Deferred taxes | 25 | 47 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (218) | (2,183) |
| Prepaid expenses and other current assets | (1,633) | (2,654) |
| Accounts payable and accrued liabilities | (3,873) | (1,290) |
| Deferred costs | (1,311) | (859) |
| Deferred revenues | 3,654 | 824 |
| Net cash provided by (used in) operating activities | 951 | (9,615) |
| Cash flows from investing activities: | ||
| Purchase of marketable securities | (7,149) | (20,987) |
| Proceeds from sales, maturities and redemptions of marketable securities | 15,626 | 38,122 |
| Purchases of property and equipment | (306) | (229) |
| Capitalized software development costs(1) | (1,363) | (1,141) |
| Net cash provided by investing activities | 6,808 | 15,765 |
| Cash flows from financing activities: | ||
| Payments for taxes related to net settlement of equity awards | (5,678) | (1,984) |
| Proceeds from stock option exercises | 1,171 | 1,416 |
| Net cash used in financing activities | (4,507) | (568) |
| Net increase in cash and cash equivalents and restricted cash | 3,252 | 5,582 |
| Cash and cash equivalents and restricted cash, beginning of period | 40,927 | 112,337 |
| Cash and cash equivalents and restricted cash, end of period | $44,179 | $117,919 |
(1)See Note 3 for additional information regarding non-cash investing activities for the three months ended March 31, 2024 and 2023 related to capitalized software development costs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.